These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10858362)

  • 1. Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection.
    Hostetler KY; Beadle JR; Hornbuckle WE; Bellezza CA; Tochkov IA; Cote PJ; Gerin JL; Korba BE; Tennant BC
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1964-9. PubMed ID: 10858362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro.
    Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA
    Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).
    Peek SF; Cote PJ; Jacob JR; Toshkov IA; Hornbuckle WE; Baldwin BH; Wells FV; Chu CK; Gerin JL; Tennant BC; Korba BE
    Hepatology; 2001 Jan; 33(1):254-66. PubMed ID: 11124844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of ganciclovir, 9-(1,3-dihydroxy-2-propoxymethyl) guanine against woodchuck hepatitis virus: quantitative measurement of woodchuck hepatitis virus DNA using storage phosphor technology.
    Zahm FE; Bonino F; Giuseppetti R; Rapicetta M
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):510-6. PubMed ID: 9836108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B.
    Menne S; Tumas DB; Liu KH; Thampi L; AlDeghaither D; Baldwin BH; Bellezza CA; Cote PJ; Zheng J; Halcomb R; Fosdick A; Fletcher SP; Daffis S; Li L; Yue P; Wolfgang GH; Tennant BC
    J Hepatol; 2015 Jun; 62(6):1237-45. PubMed ID: 25559326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.
    Cullen JM; Smith SL; Davis MG; Dunn SE; Botteron C; Cecchi A; Linsey D; Linzey D; Frick L; Paff MT; Goulding A; Biron K
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2076-82. PubMed ID: 9333028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous response for a mammalian hepadnavirus infection to acyclovir: drug-arrested intermediates of minus-strand viral DNA synthesis are enveloped and secreted from infected cells as virion-like particles.
    Tencza MG; Newbold JE
    J Med Virol; 1997 Jan; 51(1):6-16. PubMed ID: 8986943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
    Jacob JR; Korba BE; Cote PJ; Toshkov I; Delaney WE; Gerin JL; Tennant BC
    Antiviral Res; 2004 Aug; 63(2):115-21. PubMed ID: 15302140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral administration of emtricitabine on woodchuck hepatitis virus replication in chronically infected woodchucks.
    Korba BE; Schinazi RF; Cote P; Tennant BC; Gerin JL
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1757-60. PubMed ID: 10817750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of oxetanocin-G, a novel nucleoside against the woodchuck hepatitis virus.
    Ikeda N; Kaneko S; Shimoda A; Inagaki Y; Unoura M; Okada M; Yonekawa Y; Takahashi K; Kobayashi K
    J Antimicrob Chemother; 1994 Jan; 33(1):83-9. PubMed ID: 8157578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound antiviral effect of oral administration of MIV-210 on chronic hepadnaviral infection in a woodchuck model of hepatitis B.
    Michalak TI; Zhang H; Churchill ND; Larsson T; Johansson NG; Oberg B
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3803-14. PubMed ID: 19564357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-Like Receptor 8 Agonist GS-9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B.
    Daffis S; Balsitis S; Chamberlain J; Zheng J; Santos R; Rowe W; Ramakrishnan D; Pattabiraman D; Spurlock S; Chu R; Kang D; Mish M; Ramirez R; Li L; Li B; Ma S; Hung M; Voitenleitner C; Yon C; Suresh M; Menne S; Cote P; Delaney WE; Mackman R; Fletcher SP
    Hepatology; 2021 Jan; 73(1):53-67. PubMed ID: 32246499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice.
    Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Rybak RJ; Kern ER; Hostetler KY
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):471-9. PubMed ID: 10772728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver-targeted antiviral nucleosides: enhanced antiviral activity of phosphatidyl-dideoxyguanosine versus dideoxyguanosine in woodchuck hepatitis virus infection in vivo.
    Korba BA; Xie H; Wright KN; Hornbuckle WE; Gerin JL; Tennant BC; Hostetler KY
    Hepatology; 1996 May; 23(5):958-63. PubMed ID: 8621175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections.
    Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER
    Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.